1 year return (CAGR)
59.84%
ImmuCell Corporation Exchange (NASDAQ, USD)
ICCC
9.99
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
23.53%
5 year return (CAGR)
1.68%
10 year return (CAGR)
3.53%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
90.73M
Price/Sales
2.96
Ent value
97.13M
Price/Book
2.89
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
115.23
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 10.03 |
| Daily high | 10.07 |
| Daily low | 9.85 |
| Daily Volume | 8K |
| All-time high | 11.88 |
| 1y analyst estimate | 14.00 |
| Beta | 0.57 |
| EPS (TTM) | 0.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ICCC | S&P500 | |
| Current price drop from All-time high | -15.91% | -1.29% |
| Highest price drop | -93.56% | -56.47% |
| Date of highest drop | 11 Mar 1991 | 9 Mar 2009 |
| Avg drop from high | -54.89% | -10.68% |
| Avg time to new high | 217 days | 12 days |
| Max time to new high | 2324 days | 1805 days |
News
